596 filings
Page 2 of 30
8-K
d6ns5 nhkbnea7
14 Feb 23
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023
5:10pm
8-K
t3ppw10f
22 Dec 22
Regulation FD Disclosure
4:21pm
8-K
kbyq44kt8 bnci
28 Nov 22
Entry into a Material Definitive Agreement
4:05pm
8-K
ewld3
15 Nov 22
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023
12:36pm
8-K
q6jhplhleijzb6qg
10 Nov 22
Termination of a Material Definitive Agreement
4:15pm
8-K
pnamzds
2 Nov 22
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
4:30pm
8-K
w80 23qwau
7 Sep 22
Entry into a Material Definitive Agreement
4:35pm
8-K
b4qba9 ky
26 Aug 22
Termination of a Material Definitive Agreement
4:45pm
8-K
8kf2loivhr00kont
15 Aug 22
Results of Operations and Financial Condition
6:14pm
8-K
xpvvjq8cz c3d
29 Jun 22
Results of Operations and Financial Condition
5:03pm
8-K
bdwpom
29 Jun 22
Regulation FD Disclosure
9:00am
8-K
e2gybca
11 May 22
Elite Pharmaceuticals, Inc. Appoints Robert Chen as Chief Financial Officer
5:13pm
8-K
r747iah
18 Apr 22
Departure of Directors or Certain Officers
4:35pm
8-K
360xash9joxlkf41iht4
4 Apr 22
Elite Pharmaceuticals and Praxgen Pharmaceuticals Receive FDA Approval for Generic Doxycycline
11:26am
8-K
52sdpvffi12knzb4r
15 Feb 22
Results of Operations and Financial Condition
12:00am